SKIN COSMETIC
    3.
    发明专利

    公开(公告)号:JPH08119847A

    公开(公告)日:1996-05-14

    申请号:JP25318794

    申请日:1994-10-19

    Applicant: KAO CORP

    Abstract: PURPOSE: To obtain a skin cosmetic, containing ceramides or pseudoceramides having a specific structure, a dicarboxylic acid and a salt thereof, excellent in humectant ability, having a low irritant feeling and useful for the facial skin. CONSTITUTION: This skin cosmetic contains (A) ceramides or pseudoceramides of formula I or II (R and R are each a 9-39C straight-chain or branched chain saturated or unsaturated hydrocarbon group which may be substituted with one or more hydroxyl groups; R and R are each H, a phosphate residue, a sulfate residue or a saccharide residue), (B) a dicarboxylic acid of the formula HOOC-X-COOH (X is a 1-6C bivalent hydrocarbon group) (preferably malonic acid, succinic acid, fumaric acid, etc.) and (C) a salt of the dicarboxylic acid of the formula HOOC-X-COOH. Furthermore, 0.01-20wt.% ingredient (A) is preferably contained and the total amount of the contained ingredients (B) and (C) as acids is preferably 0.01-20wt.%. The blending molar ratio of the ingredient (B) to the salt of the ingredient (C) is preferably (1/9) to (9/1).

    NEW COMPOUND, VASODILATOR AND SKIN MEDICINE FOR EXTERNAL USE CONTAINING THE SAME

    公开(公告)号:JPH04211676A

    公开(公告)日:1992-08-03

    申请号:JP3689091

    申请日:1991-02-06

    Applicant: KAO CORP

    Abstract: PURPOSE:To obtain a compound such as erectumins A and B useful as a vasodilator, a skin medicine for external use, etc. CONSTITUTION:A compound expressed by formula I (R1 is H or Group expressed by formula II; R2 is H or CH3; the asterisk mark indicates asymmetric carbon atom), e.g. erectumins A and B in which R1 is the group expressed by formula II and R2 is H. The aforementioned compound is obtained by initially pulverizing Hypericum erectum Thunb., adding a solvent such as methanol or acetone to the pulverized substance, carrying out dipping and extracting at 10-60 deg.C for 1 day to 1 week, subjecting the resultant essence of the extract solution to liquid-liquid partition with methanol, water and n-hexane and fractionating the prepared n-hexane fraction.

    5ALPHA-REDUCTASE INHIBITOR
    5.
    发明专利

    公开(公告)号:JPH02193920A

    公开(公告)日:1990-07-31

    申请号:JP1348289

    申请日:1989-01-23

    Applicant: KAO CORP

    Abstract: PURPOSE:To provide the subject inhibitor having an excellent 5alpha-reductase- inhibiting activity and high safety and effective for the therapy of prostatic hypertroply, etc., caused by the action of androgenic hormone by containing an inflavone compound as an active ingredient. CONSTITUTION:A 5alpha-reductase inhibitor contains an isoflavone compound of the formula (R , R and R are H, chain or alicyclic hydrocarbon or 1-6C alkoxyl; A, B, C and D are H, hydroxyl or methoxyl, but R and C are simultaneously not H) as an active ingredient. The 5alpha-reductase inhibitor may be administered not only as such but also in the form of tablets, powder, etc. When the inhibitor is used e.g. in the form of a solid preparation, the solid preparation may contain an inert diluent such as lactose or mannitol, a lubricant such as magnesium stearate, a disintegrator such as cellulose or calcium gluconate, etc.

    COSMETIC
    6.
    发明专利
    COSMETIC 失效

    公开(公告)号:JPH08109121A

    公开(公告)日:1996-04-30

    申请号:JP24745394

    申请日:1994-10-13

    Applicant: KAO CORP

    Abstract: PURPOSE: To obtain a cosmetic, excellent in preservation stability and capable of imparting persistent humectant effects to the skin. CONSTITUTION: This cosmetic contains (A) a ceramide or its analogous substance, e.g. a ceramide of formula I (R and R are each a 10-26C straight-chain or branched chain saturated or unsaturated hydrocarbon group substitutive with one or more OH groups) or formula II (R is a 10-26C straight-chain or branched saturated or unsaturated hydrocarbon group) and (B) an oily base having ) with the component (A) calculated by a three-dimensional solubility parameter method, preferably an ester of a polyhydric alcohol with a fatty acid, especially octyldodecyl lactate or diisostearic acid diglycerol. The amounts of both the ingredients are within the range of preferably 0.1-50wt.%, especially 1-20wt.% ingredient (A) and preferably 0.1-70wt.%, especially 1-30wt.% ingredient (B). Cholesterol (derivative) or a fatty acid can be blended in the cosmetic to thereby further improve the humectant properties and feeling of use.

    SEBACEOUS GLAND SUPPRESSOR
    7.
    发明专利

    公开(公告)号:JPH02193919A

    公开(公告)日:1990-07-31

    申请号:JP1348189

    申请日:1989-01-23

    Applicant: KAO CORP

    Abstract: PURPOSE:To provide a sebaceous gland-inhibiting agent capable of effectively suppressing excess sebum, causing no side effect even when used for long periods and being employed in the forms of an emulsified cosmetic, an oily cosmetic, etc., by containing an isoflavone compound as an active ingredient. CONSTITUTION:A sebaceous gland-inhibiting agent contains an isoflavone compound of the formula (R , R and R are H, chain or alicyclir hydrocarbon or 1-6C alkoxyl; A, B, C and D are H, hydroxy or methoxy, but R and C are not H simultaneously) as an active ingredient. The isoflavone compound of the formula can be used not only is the form of the especially isolated substance but only in the state of an extract separated from a plant belonging to e.g. the Rosaceae, Moraceae, Inidaceae, etc., as well as to two the subfamilies of the Leguminosae. When used an emulsified skin cosmetic or a hair cosmetic, the compound or extract is suitably compounded in the preparation in an amount of 0.005-5.0wt.% or 0.001-50%, respectively.

    DERMAL EXTERNAL MEDICINE
    10.
    发明专利

    公开(公告)号:JPH04221305A

    公开(公告)日:1992-08-11

    申请号:JP41180390

    申请日:1990-12-20

    Applicant: KAO CORP

    Abstract: PURPOSE:To provide the title medicine having peripheral vascular dilation activity, thus excellent in the preventive and therapeutic effect for skin diseases, containing a camphor derivative. CONSTITUTION:The objective medicine containing, as active ingredient, a compound of formula I [Q is -(CH2)2-, -(CH2)3-or of formula II; R is OH, 1-5C alkanoyloxy or 1-5C alkoxy; R is H or 1-5C alkyl, or R and R are joined into O] or its salt. The present medicine has excellent peripheral vascular dilation activity, esp. improving effect for dermal bloodstream, thus being greatly useful as a therapeutic agent for various skin diseases due to the inadequate blood circulation in the skin and as a cosmetic.

Patent Agency Ranking